Last update 31 May 2026

Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
SDBH-MSC-101
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Originator Organization
Peking University People's Hospital
Active Organization
Qilu Hospital of Shandong UniversityQilu Hospital of Shandong University
Inactive Organization
Peking University People's Hospital
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)
NCT07605559
/ Not yet recruitingNot ApplicableIIT
A Multi-center Study on Umbilical Cord-derived Mesenchymal Stem Cell Injectables for the Regeneration of Partial-thickness Rotator Cuff Tears
ChiCTR2200058116
/ SuspendedPhase 1
LISW Therapy With Umbilical Cord Derived Stem Cells for Diabetic Erectile Dysfunction
ChiCTR1900022423
/ RecruitingPhase 1IIT
Immune mechanism and clinical efficacy of umbilical cord mesenchymal stem cells in the treatment of ulcerative colitis
100 Clinical Results associated with Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)
Login to view more data
100 Translational Medicine associated with Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)
Login to view more data
100 Patents (Medical) associated with Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)
Login to view more data
100 Deals associated with Umbilical Cord-derived Mesenchymal Stem Cells(Peking University People's Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 1
China
Qilu Hospital of Shandong UniversityQilu Hospital of Shandong University
24 Mar 2026
Rheumatoid ArthritisPhase 1
China
Peking University People's Hospital
24 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free